DOI:
10.1055/s-00027015
Planta Medica Letters
LinksClose Window
References
Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ.
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.
Blood 2007;
110: 3281-3290
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.